ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

OPTI Optibiotix Health Plc

14.75
-0.50 (-3.28%)
05 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Optibiotix Health Plc LSE:OPTI London Ordinary Share GB00BP0RTP38 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.50 -3.28% 14.75 14.50 15.00 15.25 14.50 15.25 68,434 14:37:58
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Noncomml Resh Organizations 457k 2.59M 0.0284 5.19 13.91M
Optibiotix Health Plc is listed in the Noncomml Resh Organizations sector of the London Stock Exchange with ticker OPTI. The last closing price for Optibiotix Health was 15.25p. Over the last year, Optibiotix Health shares have traded in a share price range of 7.35p to 43.50p.

Optibiotix Health currently has 91,190,661 shares in issue. The market capitalisation of Optibiotix Health is £13.91 million. Optibiotix Health has a price to earnings ratio (PE ratio) of 5.19.

Optibiotix Health Share Discussion Threads

Showing 24426 to 24447 of 147900 messages
Chat Pages: Latest  984  983  982  981  980  979  978  977  976  975  974  973  Older
DateSubjectAuthorDiscuss
08/5/2017
17:37
Keep calm boys, we will be fine. DIAMOND.
diamond fibre
08/5/2017
16:45
Why is it one gets nervous (and for the wrong reasons) when an OPTI RNS/Product Launch/up-date is in the offing. When,I wonder, will such event trigger a much-deserved (and much coveted) share price uplift? Perversely, early-day investors had appreciably greater paper-profits racked up when all the bits and pieces that have happened along in recent times, were aspirational. Recent experience suggests the market is an ass; let's look forward to the (imminent?) day when it twigs what's going on here.
owenmo
08/5/2017
16:02
It would be great to get an RNS with figures attached, but I doubt very much this could happen at the moment due to different outlets of the same product with different price structures for different companies based on sizes of orders etc. If price info is in public domain it would reduce Opti flexibility in making deals. I would expect this to change over time though.
What would be good is to have some upbeat guidance on break even/ profitability point, without giving the game away...

nicktopten
08/5/2017
15:59
Staying above the body of Friday's hammer*, as we have today, bodes well.

Next - a two day close above the 8 day ESA, please.

M


*Your charts show an inverted hammer.

marnewton
08/5/2017
15:51
I know I'm not the only investor expecting an LP-LDL related RNS tomorrow, or at some point this week naming Nutrilinea as a partner. If so, I expect it will be in SOH typical style, ultra conservative. If it is drafted by SOH, which is usually the case, it will be because his idea is to be ultra conservative while production/sales increase. By adopting this strategy he thinks he cannot be held to ransom by brokers and bloggers. Of course, this in his eyes is probably better than being held to ransom by PI's?

To my way of thinking I see this as a very good strategy for the LONG vision as it allows the very patient investors time to get their house in order and accumulate. As and when the wider market wakes up to this strategy of over conservative (assuming sales do ramp up quicker than expected) then the uplift in the share price will be much greater as each production pipeline is launched in each respective territory. Soon the LP-LDL focus will move towards the US partner, which has already been leaked by TW as being P&G. This is where TW speculated telephone numbers were expected. I don't think we will get telephone numbers in an RNS. The assumption is telephine number because of the size of P&G as a company and the size of the US market for LP-LDL. I'm confident if and when P&G are finally named as a partner this will give even the short term PI's a boost of confidence, even without telephone numbers in the RNS because I think the assumption is P&G have walked, which if we believe; 1: TW leaked P&G story 2: SOH publically stating no partner had walked, then 1+1=2.

elrico
08/5/2017
15:51
Ha ha, agreed branboyd.
But it's a small step in the right direction for now.
John

2350220
08/5/2017
15:32
2p is hardly a recovery
branboyd1
08/5/2017
15:25
Recovery gaining momentum...
parob
08/5/2017
15:05
Yep. I got a few more at 65.38. Better timed than my last top up at 81!
bernieboy
08/5/2017
14:37
No one was buying because the momentum was down. Seems like we've seen the bottom. 70p+ by end of week.
riskybusiness1
08/5/2017
14:24
I've gone for another £4k into my ISA this morning.
John

2350220
08/5/2017
14:07
Yes, good to see some buying ahead of tomorrow.
rafboy
08/5/2017
14:02
Buying ahead of tomorow seems to be picking up. It's a shame it never started last week.
bobdown2
08/5/2017
11:56
SOH was saying at the presentation that there would be a new partner showcasing the LPLDL product at Vitafoods tomorrow, so surely we should get an RNS naming them tomorrow?
deeppockets
08/5/2017
10:25
Let's hope we get lots of news over a short period because we are still seeing the same sort of trades like we have recently.
bobdown2
08/5/2017
10:06
Nice flurry of buys on SBTX this morn, I think the IPO overhang is clearing, should see share price tick up soon in expectation of the human skin study results.Just a hunch but I think the SBTX news will arrive before the OPTI 'free' shares announcement, the higher the SBTX share price the better the deal
trotterstrading
08/5/2017
09:05
J.h I have to disagree. The price has fallen over 20 per cent and the product launch is good news not bad. The share price has Sacco and Tata priced in but not tomorrow's launch. The selling has distorted the share price and only normal trading will put the share price to the level it should be at.
bobdown2
08/5/2017
09:02
JH, let's wait and see but I can't believe the share price will drop much further from here.
rafboy
08/5/2017
08:58
rafboy the launch is already discounted.Its positive news along with the launch that be would be a boost.
The declinehas stopped for now as traders buy in pre launch, no additional news and the share price goes lower imho.

john henry
08/5/2017
08:41
Market will not care about launch, it expects orders with £ signs.
branboyd1
08/5/2017
08:38
All buys so far except the 8K sell. 20K buy just showing on nex at 65.8p. Fingers crossed 65 was the bottom.
parob
08/5/2017
07:56
Hoping for a better day here today. Lead up to tomorrow's launch could be interesting.
rafboy
Chat Pages: Latest  984  983  982  981  980  979  978  977  976  975  974  973  Older

Your Recent History

Delayed Upgrade Clock